.
BUDGET 2012
 | News | Market | Portfolio | Messages
SENSEX  22,277.23  -207.70
NIFTY  6,675.30  -57.80
Go to Moneycontrol Home
Pharmaceuticals
Crisil reaffirms 'A1+' rating on Ranbaxy's bank facilities
The ratings continue to reflect Ranbaxy's established position in the international generics market and in the Indian fo
Sun plans gradual phase-out of Ranbaxy-branded drugs in US
Exports to EU from Ranbaxy's two plants to remain suspended
CCI clears Torrent-Elder Pharma Rs 2,000 cr deal
Lupin gets USFDA approval for diabetes management drug
STOCK RECOMMENDATION
Stock Advice
Glenmark Pharma may test Rs 630: Amit Harchekar
Go long in Biocon: Ashish Chaturmohta
Buy Biocon, HCL Tech; short JSW Steel, OBC: Rakesh Gandhi
more
Broker Reports
Accumulate Sun Pharma; target of Rs 646: P Lilladher
Buy Ipca Laboratories; target of Rs 954: Microsec
Buy Natco Pharma; target Rs 800: ICICIdirect
more
Budget 2012
HOME
Font Size: S M L
Mobile | Classic
Customer Support
© 2011. a Web18 Venture